Infective endocarditis

From IDWiki
Revision as of 21:39, 9 March 2020 by Aidan (talk | contribs) (: rearranged table and added enterococci)

Background

  • Infection of heart valves, either prosthetic or native

Organisms

Clinical Presentation

Management

  • Varies by causative organism and prosthetic vs. native valve
Indication Antibiotic Dose Duration Notes
MSSA and other oxacillin-susceptible Staphylococcus
NVE oxacillin 12 g/day IV in 4-6 doses 6 weeks can treat for 2 weeks in uncomplicated right-sided NVE
NVE cefazolin 6 g/day IV in 3 doses 6 weeks in patients with non-anaphylactoid penicillin allergy
PVE oxacillin, plus 12 g/day in 6 doses ≥6 weeks use cefazolin or vancomycin if allergy
rifampin, plus 900 mg/day IV/PO in 3 doses
gentamicin 3 mg/kg/day IV/IM in 2-3 doses 2 weeks
MRSA and other oxacillin-resistant Staphylococcus
NVE vancomycin 30 mg/kg/day IV in 2 doses 6 weeks target trough 10-20 μg/mL
NVE daptomycin ≥8 mg/kg/dose 6 weeks
PVE vancomycin, plus 30 mg/kg/day in 2 doses ≥6 weeks target vancomycin trough of 10-20 μg/mL
rifampin, plus 900 mg/day IV/PO in 3 doses
gentamicin 3 mg/kg/day IV/IM in 2-3 doses 2 weeks
Enterococcus susceptible to penicillin and gentamicin
NVE or PVE ampicillin, plus 2 g IV q4h 4-6 weeks 4 weeks if symptoms <3 months; 6 weeks if symptoms >3 months or if PVE
gentamicin 3 mg/kg IBW in 2-3 doses
NVE or PVE ampicillin, plus 2 g IV q4h 6 weeks alternative regimen if CrCl <50
ceftriaxone 2 g IV q12h
Enterococcus susceptible to penicillin and resistant to aminoglycosides
NVE or PVE ampicillin, plus 2 g IV q4h 6 weeks
ceftriaxone 2 g IV q12h
Enterococcus resistant to penicillin and susceptible to vancomycin and aminoglycosides
NVE or PVE vancomycin, plus 30 mg/kg/day IV in 2 doses 6 weeks
gentamicin 3 mg/kg/day IV/IM in 3 doses
Enterococcus resistant to penicillin, aminoglycosides, and vancomycin
NVE or PVE linezolid 600 mg IV/PO q12h >6 weeks
NVE or PVE daptomycin 10-12 mg/kg/dose >6 weeks